Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | 680,299 | reported | 02 Mar 2026 | tx 20+1,352,689−285,059 |
| Sucampo Pharmaceuticals, Inc. | 0 | reported | 13 Feb 2018 | tx 22+260,328−435,328 |
1 purchase reported after at least 12 months of silence — most recent on 21 Nov 2022.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 40,761 | 14.21 USD | |
| 27 Feb 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 58,160 | 0.00 USD | |
| 27 Feb 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 97,256 | 0.00 USD | deriv |
| 20 Feb 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 32,901 | 14.40 USD | |
| 02 Jan 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 42,787 | 15.95 USD | |
| 02 Jan 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 54,166 | 0.00 USD | |
| 03 Mar 2025 | SALE | Aurinia Pharmaceuticals Inc. | 65,902 | 8.00 USD | |
| 03 Mar 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 135,567 | 0.00 USD | |
| 28 Feb 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 82,781 | 0.00 USD | |
| 04 Mar 2025 | SALE | Aurinia Pharmaceuticals Inc. | 58,991 | 7.92 USD | |
| 28 Feb 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 126,416 | 0.00 USD | deriv |
| 06 Mar 2024 | SALE | Aurinia Pharmaceuticals Inc. | 40,665 | 5.51 USD | |
| 20 Feb 2024 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 216,666 | 0.00 USD | |
| 02 Mar 2023 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 271,134 | — | |
| 21 Nov 2022 | PURCHASE | Aurinia Pharmaceuticals Inc. | 10,000 | 4.66 USD | first after silence |
| 02 Mar 2022 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 8,500 | 0.00 USD | |
| 02 Mar 2022 | SALE | Aurinia Pharmaceuticals Inc. | 3,052 | 12.01 USD | |
| 02 Mar 2022 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 104,080 | 0.00 USD | deriv |
| 02 Mar 2022 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 178,063 | 0.00 USD | deriv |
| 11 May 2021 | PURCHASE | Aurinia Pharmaceuticals Inc. | 9,900 | 10.07 USD | |
| 13 Feb 2018 | GRANT_AWARD | Sucampo Pharmaceuticals, Inc. | 36,975 | 18.00 USD | |
| 13 Feb 2018 | OTHER | Sucampo Pharmaceuticals, Inc. | 150,000 | 10.60 USD | deriv |
| 13 Feb 2018 | OTHER | Sucampo Pharmaceuticals, Inc. | 25,000 | 11.25 USD | deriv |
| 13 Feb 2018 | OTHER | Sucampo Pharmaceuticals, Inc. | 28,000 | 3.18 USD | deriv |
| 13 Feb 2018 | OTHER | Sucampo Pharmaceuticals, Inc. | 75,000 | 4.20 USD | deriv |